$13.85
1.39%
Nasdaq, Sep 02, 10:00 pm CET
ISIN
US14167L1035
Symbol
CDNA

CareDx, Inc. Stock price

$13.85
+1.25 9.92% 1M
-7.28 34.45% 6M
-7.56 35.31% YTD
-16.88 54.93% 1Y
-4.48 24.44% 3Y
-20.48 59.66% 5Y
+6.87 98.42% 10Y
+4.80 53.04% 20Y
Nasdaq, Closing price Tue, Sep 02 2025
+0.19 1.39%
ISIN
US14167L1035
Symbol
CDNA
Industry

Key metrics

Basic
Market capitalization
$737.2m
Enterprise Value
$550.9m
Net debt
positive
Cash
$186.3m
Shares outstanding
53.2m
Valuation (TTM | estimate)
P/E
14.6 | 24.3
P/S
2.2 | 2.0
EV/Sales
1.6 | 1.5
EV/FCF
46.4
P/B
2.3
Financial Health
Equity Ratio
77.1%
Return on Equity
13.9%
ROCE
-14.0%
ROIC
-21.9%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$340.8m | $377.3m
EBITDA
$-46.6m | $30.8m
EBIT
$-49.2m | $12.8m
Net Income
$51.7m | $30.3m
Free Cash Flow
$11.9m
Growth (TTM | estimate)
Revenue
14.7% | 13.0%
EBITDA
36.8% | 160.2%
EBIT
35.6% | 123.8%
Net Income
132.4% | -42.4%
Free Cash Flow
153.3%
Margin (TTM | estimate)
Gross
66.9%
EBITDA
-13.7% | 8.2%
EBIT
-14.4%
Net
15.2% | 8.0%
Free Cash Flow
3.5%
More
EPS
$1.0
FCF per Share
$0.2
Short interest
12.5%
Employees
647
Rev per Employee
$520.0k
Show more

Is CareDx, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.

CareDx, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

14 Analysts have issued a CareDx, Inc. forecast:

10x Buy
71%
4x Hold
29%

Analyst Opinions

14 Analysts have issued a CareDx, Inc. forecast:

Buy
71%
Hold
29%

Financial data from CareDx, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
341 341
15% 15%
100%
- Direct Costs 113 113
8% 8%
33%
228 228
18% 18%
67%
- Selling and Administrative Expenses 205 205
7% 7%
60%
- Research and Development Expense 69 69
8% 8%
20%
-47 -47
37% 37%
-14%
- Depreciation and Amortization 2.54 2.54
1% 1%
1%
EBIT (Operating Income) EBIT -49 -49
36% 36%
-14%
Net Profit 52 52
132% 132%
15%

In millions USD.

Don't miss a Thing! We will send you all news about CareDx, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

CareDx, Inc. Stock News

Neutral
Business Wire
about 18 hours ago
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that it has submitted its comment letter in response to the draft Local Coverage Determin...
Neutral
Business Wire
13 days ago
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers — today announced the company will participate in a fireside chat at the Wells Fargo Healthcare Conference ...
Positive
The Motley Fool
27 days ago
CareDx (CDNA) EPS Beats Sales Gain 14%
More CareDx, Inc. News

Company Profile

CareDx, Inc. operates as a transplant diagnostics company,which discovers, develops, and commercializes diagnostic solutions. Its product includes AlloMap, AlloSure, and Laboratory products. The company was founded on December 21, 1998 and is headquartered in Brisbane, CA.

Head office United States
CEO John Hanna
Employees 647
Founded 1998
Website www.caredx.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today